Multi-omics insights into the pathogenesis of diabetic cardiomyopathy: epigenetic and metabolic profiles

Aim Diabetic cardiomyopathy (DbCM), a complex metabolic disease, greatly threatens human health due to therapeutic limitations. Multi-omics approaches facilitate the elucidation of its intrinsic pathological changes.